Institutions Holding Call Options on Arbutus Biopharma Corp (ABUS)
This table provides information about the call option holders of Arbutus Biopharma Corp (ABUS). We have compiled data on the institutions that hold call options on the stock, with a total of 982,200 call options outstanding, which have been reported (via 13F filing form) to have a value of $3.34 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
354,900
calls
|
$1.21 Million
0.0% of portfolio
|
N/A
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
269,200
calls
|
$915,280
0.0% of portfolio
|
N/A
|
|
|
Eisler Capital Management Ltd.
London, X0 |
Aug 12, 2025 Q2 2025 |
123,200
calls
|
$418,880
0.0% of portfolio
|
Q2 2025
Added 2.67%
|
|
|
Nomura Holdings Inc
Tokyo, M0 |
Aug 14, 2025 Q2 2025 |
100,000
calls
|
$340,000
0.0% of portfolio
|
N/A
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
71,200
calls
|
$242,080
0.0% of portfolio
|
N/A
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
27,700
calls
|
$94,180
0.0% of portfolio
|
Q2 2025
Reduced 50.45%
|
|
|
Wolverine Trading, LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
26,700
calls
|
$90,780
0.0% of portfolio
|
N/A
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
9,300
calls
|
$31,620
0.0% of portfolio
|
Q2 2025
New holding
|